10 Best Telehealth Stocks to Buy Now

6. Hims & Hers Health, Inc. (NYSE:HIMS)

Number of Hedge Fund Holders: 38

Hims & Hers Health, Inc. (NYSE:HIMS) operates a telehealth consultation platform that connects healthcare professionals to consumers, allowing access to medical care for sexual health, mental health, dermatology, and primary care.

The company estimates a notable 87% to 94% year-over-year revenue growth for fiscal Q1 2025, reaching up to $540 million and up from 69% in fiscal Q4 2024. It also expects an EPS of $0.11. This growth momentum highlights Hims & Hers Health, Inc.’s (NYSE:HIMS) direct-to-consumer model that allows expedited data collection, product iteration, and patient feedback loops that boost growth and improve outcomes. The company thus holds a strategic edge due to this data and AI-driven personalization.

In addition, Hims & Hers Health, Inc. (NYSE:HIMS) announced its entry into peptide manufacturing in February 2025, which marks an early move into the GLP-1 trend. Production is anticipated to start around 2026, positioning the company to offer personalized peptide therapies, likely to be guided by AI.

Hims & Hers Health, Inc. (NYSE:HIMS) also has US-based manufacturing, which means its growth trajectory is not impeded by tariff concerns or macroeconomic headwinds. The company appears positioned to thrive in this volatility, supported by its resilient operations, inelastic demands, and cost-saving advantages. According to our list, it is the sixth-best telehealth stock to invest in. ClearBridge Small Cap Growth Strategy stated the following regarding Hims & Hers Health, Inc. (NYSE:HIMS) in its Q1 2025 investor letter:

“We continued to generate a number of compelling new ideas, adding five new investments that we still held at quarter end: Glaukos, Rocket Lab USA, Karman Holdings (through its IPO), Archrock, Hims & Hers Health, Inc. (NYSE:HIMS) and Geron.

Hims & Hers is a healthcare IT services company providing a consumer telehealth platform across a variety of men’s and women’s health categories, including weight loss, dermatology, and mental health. With an integrated experience, strong brand recognition, and a convenient stigma-free value proposition to consumers, the company is seeing robust revenue growth while improving profitability.”